Quality of Life of Patients on Maintenance Hemodialysis in Relation to Hemoglobin Level: A Multicenter Study from a Developing Country

Authors

  • Shudhanshu Kumar Saha Registrar, Nephrology, BIRDEM General Hospital, Dhaka
  • Mohammad Abul Masur Director, Transplant unit, BADAS, Dhaka
  • Sohel Reza Choudhury Department of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka
  • Md Abdul Wahab Khan Consultant, Square Hospital Ltd, Dhaka
  • Masud Iqbal Associate Professor of Nephrology, SSMCH, Dhaka
  • Ayub Ali Choudhury Department of Nephrology, NIKDU, Dhaka
  • Rafi Nazrul Islam Assistant Registrar, Nephrology, BIRDEM General Hospital, Dhaka
  • Sarwar Iqbal Professor & Head, Department of Nephrology, BIRDEM General Hospital, Dhaka

DOI:

https://doi.org/10.3329/birdem.v7i3.33780

Keywords:

Hemodialysis, hemoglobin, quality of life

Abstract

Background: Anemia is common in patients with end stage renal disease (ESRD) and is associated with impaired quality of life (QOL). This study was done to evaluate the QOL of ESRD patients on maintenance hemodialysis (MHD) with different levels of hemoglobin (Hb).

Methods: This cross-sectional study was conducted from January to December 2013 on 135 adult ESRD patients on MHD for ?4 months, at hemodialysis units of three tertiary care hospitals in Dhaka, Bangladesh. The patients were divided into three groups based on Hb levels (Group 1: Hb <9 gm/dl, n=45, 33%; Group 2: Hb 9-11 gm/dl, n=53, 39% and Group 3: Hb >11 gm/dl, n=37, 28%), provided their Hb levels were stable [ie. maintained with erythropoietin (EPO) or blood transfusion (BT) or both] over the previous four months. Subjects were interviewed by principal investigator using Kidney Disease Quality of Life Short Form Tool (KDQOL-SF-36 version 1.3) consisting of two domains with 38 questions with each item put on a 0 to 100 range, higher scores indicating better QOL.

Results: The mean age was 50+12 years with male predominance (male:female = 1.5:1). Mean duration of hemodialysis was 12±11.8 months (range 9 to 66 months). The average QOL score was 50. Comparison of QOL parameters between the three groups showed that symptoms/problems, effects of kidney disease, burden of kidney disease, cognitive function, quality of social interaction and sleep in the kidney disease specific domain as well as pain, emotional well-being, social function and energy/fatigue scale scores in the general health related domain were significantly higher in the group 2 and group 3 than group 1 patients (each with p<0.001). Comparison of QOL parameters between anemia correction measures like EPO (n=65, 48.2%), BT (n=42, 31.1%) or both (n=28, 20.7%) showed that the group receiving EPO alone had better QOL [symptom/ problem (p 0.043), burden of kidney disease (p 0.000), sexual function (p 0.000), pain (p 0.008) and energy/ fatigue (p 0.036)] compared to those getting BT or even BT plus EPO.

Conclusion: Patients were found to have better QOL with higher Hb levels. The overall QOL can be improved significantly by correction of anemia.

Birdem Med J 2017; 7(3): 198-204

Downloads

Download data is not yet available.
Abstract
851
PDF
1146

Author Biography

Shudhanshu Kumar Saha, Registrar, Nephrology, BIRDEM General Hospital, Dhaka



Downloads

Published

2017-08-30

How to Cite

Saha, S. K., Masur, M. A., Choudhury, S. R., Khan, M. A. W., Iqbal, M., Choudhury, A. A., Islam, R. N., & Iqbal, S. (2017). Quality of Life of Patients on Maintenance Hemodialysis in Relation to Hemoglobin Level: A Multicenter Study from a Developing Country. BIRDEM Medical Journal, 7(3), 198–204. https://doi.org/10.3329/birdem.v7i3.33780

Issue

Section

Original Articles